Sommario

• • ·An exciting time for antifungal therapy

    Pagina :763

     
• • ·Imprinted hybrid immunity against XBB reinfection

    Pagina :764-765

    Rosemary J Boyton, Daniel M Altmann

     
• • ·Real-world use of nirmatrelvir–ritonavir: who benefits?

    Pagina :765-767

    Kyle C Molina, Adit A Ginde

     
• • ·The ups and downs of observational vaccine research

    Pagina :767-768

    Noam Barda

     
• • ·Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox?

    Pagina :768-769

    Dimie Ogoina, Nathalie Strub-Wourgaft

     
• • ·Progress in preventing non-ventilator-associated hospital-acquired pneumonia

    Pagina :769-771

    Michael Klompas

     
• • ·Balancing adjunctive therapy for tuberculosis treatment

    Pagina :771-772

    Norbert Ndjeka, Jennifer Furin

     
• • ·Nirsevimab-resistant respiratory syncytial virus strains are rare but there

    Pagina :773-774

    Mark E Peeples, Ilada Thongpan

     
• • ·A new formulation of praziquantel to achieve schistosomiasis elimination

    Pagina :774-776

    Guo-Jing Yang, Xiao-Nong Zhou

     
• • ·Prevention of long COVID: progress and challenges

    Pagina :776-777

    Ziyad Al-Aly

     
• • ·Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis

    Pagina :778-780

    Anthony J Garcia-Prats, Graeme Hoddinott, Pauline Howell, Jennifer Hughes, Patrick Jean-Philippe, Soyeon Kim, Megan Palmer, H Simon Schaaf, James A Seddon, Elin Svensson, Anneke C Hesseling

     
• • ·The dangers of using large language models for peer review

    Pagina :781

    Tjibbe Donker

     
• • ·Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

    Pagina :781-784

    Edward J Carr, Mary Y Wu, Joshua Gahir, Ruth Harvey, Hermaleigh Townsley, Chris Bailey, Ashley S Fowler, Giulia Dowgier, Agnieszka Hobbs, Lou Herman, Martina Ragno, Murad Miah, Phillip Bawumia, Callie Smith, Mauro Miranda, Harriet V Mears, Lorin Adams, Emine Haptipoglu, Nicola O’Reilly, Scott Warchal, Chelsea Sawyer, Karen Ambrose, Gavin Kelly, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Steve Gamblin, George Kassiotis, Vincenzo Libri, Bryan Williams, Charles Swanton, Sonia Gandhi, David LV Bauer, Emma C Wall, Crick COVID Serology Consortium

      
• • ·Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022

    Pagina :784-786

    Oskar Ljungquist, Oleksandr Nazarchuk, Gunnar Kahlmeter, Vigith Andrews, Thalea Koithan, Lisa Wasserstrom, Dmytro Dmytriiev, Nadiia Fomina, Vira Bebyk, Erika Matuschek, Kristian Riesbeck

     
• • ·Tracheobronchial tuberculosis and its sequelae in children and adolescents

    Pagina :786

    Ming-Jin Yang, Jian-Qing He, Shu-Liang Guo

    
• • ·Engaging pharmacists and medicine vendors in antimicrobial stewardship in LMICs

    Pagina :786-787

    Charity Oga-Omenka, Ukamaka Okafor, Giorgia Sulis

    
• • ·Correction to Lancet Infect Dis 2023; published online May 4. https://doi.org/10.1016/S1473-3099(23)00121-4

    Pagina :e227

    
• • ·Participatory research for improving Inuit health

    Pagina :788

    Priya Venkatesan

     
• • ·Statin use in people living with HIV

    Pagina :789

    Priya Venkatesan

     
• • ·Brazil tackles its tuberculosis burden

    Pagina :790

    Sanjeet Bagcchi

     
• • ·Maintaining a robust pipeline of antibiotics

    Pagina :791

    Timothy Jesudason

     
• • ·A new network for pathogen surveillance

    Pagina :792-793

    Talha Burki

     
• • ·Infectious disease surveillance update

    Pagina :793

    Ruth Zwizwai

    Mappa Mappa
• • ·Research in brief

    Pagina :794

    Sharmila Devi

    Mappa Mappa
• • ·James Banta

    Pagina :795

    Sanjeet Bagcchi

     
• • ·James Ward—tackling STIs in Indigenous Australians

    Pagina :796

    Tony Kirby

     
• • ·How to survive to the COVID-19 pandemic

    Pagina :797

    Georgia Bisbas

     
• • ·“West” vs “Rest”—Epidemic Orientalism

    Pagina :798

    Hollie Sherwood-Martin

     
• • ·Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study

    Pagina :799-805

    Celine Y Tan, Calvin J Chiew, Deanette Pang, Vernon J Lee, Benjamin Ong, David Chien Lye, Kelvin Bryan Tan

    Riassunto Riassunto Mappa Mappa   
• • ·Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system

    Pagina :806-815

    Joseph A Lewnard, John M McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K Ackerson, Bruno J Lewin, Jeniffer S Kim, Sally F Shaw, Harpreet Takhar, Luis Jodar, Sara Y Tartof

    Riassunto Riassunto Mappa Mappa   
• • ·Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study

    Pagina :816-827

    Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, Peter Coyle, Hadi M Yassine, Asmaa A Al Thani, Hebah A Al-Khatib, Mohammad R Hasan, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul-Rahim, Gheyath K Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A Butt, Hamad Eid Al-Romaihi, Mohamed H Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Jeremy Samuel Faust, Laith J Abu-Raddad

    Riassunto Riassunto Mappa Mappa   
• • ·Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study

    Pagina :828-835

    Marta Bertran, Nick Andrews, Chloe Davison, Bennet Dugbazah, Jacob Boateng, Rachel Lunt, Joanne Hardstaff, Melanie Green, Paula Blomquist, Charlie Turner, Hamish Mohammed, Rebecca Cordery, Sema Mandal, Colin Campbell, Shamez N Ladhani, Mary Ramsay, Gayatri Amirthalingam, Jamie Lopez Bernal

    Riassunto Riassunto Mappa Mappa   
• • ·Prevention of non-ventilator-associated hospital-acquired pneumonia in Switzerland: a type 2 hybrid effectiveness–implementation trial

    Pagina :836-846

    Aline Wolfensberger, Lauren Clack, Stefanie von Felten, Mirjam Faes Hesse, Dirk Saleschus, Marie-Theres Meier, Katharina Kusejko, Roger Kouyos, Leonhard Held, Hugo Sax

    Riassunto Riassunto Mappa Mappa   
• • ·Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial

    Pagina :847-855

    Gail B Cross, Intan P Sari, Cissy Kityo, Qingshu Lu, Yogesh Pokharkar, Rajesh B Moorakonda, Han-Nguyen Thi, Quyet Do, Victoria B Dalay, Emmanuel Gutierrez, Vincent M Balanag, Randy J Castillo, Henry Mugerwa, Felic Fanusi, Philip Kwan, Ka Lip Chew, Nicholas I Paton, ROSETTA trial team, Cissy Kityo, Henry Mugerwa, Dinah Tumukunde, Joseph Akol, Do Quyet, Han Nguyen, Xuan Su Hoang, Thu Ha Doan, Victoria Dalay, Emmanuel Gutierrez, Vincent Balanag, Randy Joseph Castillo, Monica Barcelo, Rholine Gem Martin S. Veto, Maria Begonia R. Baliwagan, Glenn Balane, Anthony Geronimo, Rupert Rey Flores, Yogesh Pokharkar, Rajesh Babu Moorakonda, Qingshu Lu, Xuanhui Ng, Shanice Tan, Nicholas Iain Paton, Gail Brenda Cross, Intan Permata Sari, Ka Lip Chew, Felic Fanusi, Philip Kwan, Anthony Dominic Kelleher, Christina Chang

    Riassunto Riassunto Mappa Mappa   
• • ·Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    Pagina :856-866

    Deidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, Christopher Morehouse, Michael E Abram, Bahar Ahani, Anastasia A Aksyuk, Eugenio Baraldi, Tyler Brady, Albert Tian Chen, Hsin Chi, Eun Hwa Choi, Robert Cohen, Daria M Danilenko, Vancheswaran Gopalakrishnan, Anne Greenough, Terho Heikkinen, Mitsuaki Hosoya, Christian Keller, Elizabeth J Kelly, Leyla Kragten-Tabatabaie, Federico Martinón-Torres, Abiel Homero Mascareñas de Los Santos, Marta C Nunes, María Angélica Palomino, Jesse Papenburg, Jeffrey M Pernica, Peter Richmond, Renato T Stein, Kevin M Tuffy, Charl Verwey, Mark T Esser, David E Tabor, Louis J Bont, INFORM-RSV Study Group, Pascale Clement, Atul Gupta, Koichi Hashimoto, Kseniya Komissarova, Matt Laubscher, Magali Lumertz, Elena Priante, Irene Rivero-Calle, Ushma Wadia, Ki Wook Yun

    Riassunto Riassunto Mappa Mappa   
• • ·Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d’Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

    Pagina :867-876

    Eliézer K N’Goran, Maurice R Odiere, Ronald Assandé Aka, Mamadou Ouattara, N A David Aka, Bernhards Ogutu, Fredrick Rawago, Wilhelmina M Bagchus, Matthias Bödding, Elly Kourany-Lefoll, Aliona Tappert, Xiaoyan Yin, Deon Bezuidenhout, Henk Badenhorst, Eric Huber, Benjamin Dälken, Okba Haj-Ali Saflo

    Riassunto Riassunto Mappa Mappa   
• • ·Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review

    Pagina :e228

    Stephen Rice, Katherine Carr, Pauline Sobiesuo, Hosein Shabaninejad, Giovany Orozco-Leal, Vasileios Kontogiannis, Christopher Marshall, Fiona Pearson, Najmeh Moradi, Nicole O’Connor, Akvile Stoniute, Catherine Richmond, Dawn Craig, Benedetta Allegranzi, Alessandro Cassini

    Riassunto Riassunto Mappa Mappa   
• • ·Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs

    Pagina :e240

    Ishmeala Rigby, Melina Michelen, Andrew Dagens, Vincent Cheng, Dania Dahmash, Eli Harriss, Eika Webb, Erhui Cai, Samuel Lipworth, Alexandra Oti, Valeria Balan, Helen Piotrowski, Robert Nartowski, Amanda Rojek, Helen Groves, Peter Hart, Muge Cevik, Henry Kyobe Bosa, Lucille Blumberg, Tom E Fletcher, Peter W Horby, Shevin T Jacob, Louise Sigfrid

    Riassunto Riassunto Mappa Mappa   
• • ·Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?

    Pagina :e253

    Els Torreele, Yap Boum, Ismael Adjaho, Franck Guy Biaou Alé, Sal Ha Issoufou, Geza Harczi, Chibuzo Okonta, Piero Olliaro

    Riassunto Riassunto Mappa Mappa   
• • ·Redefining Clostridioides difficile infection antibiotic response and clinical outcomes

    Pagina :e259

    Anne J Gonzales-Luna, Andrew M Skinner, Carolyn D Alonso, Emilio Bouza, Oliver A Cornely, Tim G J de Meij, Richard J Drew, Kevin W Garey, Dale N Gerding, Stuart Johnson, Stacy A Kahn, Haru Kato, Ciaran P Kelly, Colleen R Kelly, Larry K Kociolek, Ed J Kuijper, Thomas Louie, Thomas V Riley, Thomas J Sandora, Maria J G T Vehreschild, Mark H Wilcox, Erik R Dubberke, The EXPAND Cdiff group

    Riassunto Riassunto Mappa Mappa   
• • ·Serpiginous-like choroiditis in ocular tuberculosis

    Pagina :877

    Mudit Tyagi, Khushboo Chauhan

     
• • ·Trichophyton rubrum-induced Majocchi’s granuloma in an immunocompromised patient

    Pagina :878

    Evangelia Vetsiou, Douglas Maslin, David A Enoch, Thomas Ha